Tokyo, Aug. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062531) titled 'Study to investigate pain sensitivity in patients with adrenal insufficiency' on Aug. 10.
Study Type:
Observational
Primary Sponsor:
Institute - St. Marianna University School of Medicine
Condition:
Condition - Adrenal insufficiency
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to assess pain in patients with adrenal insufficiency using Pain Vision, a minimally invasive, simple, quantitative, and objective method for pain evaluation. This study
will compare pain among patients with different clinical backgrounds, evaluate treatment-related changes in pain, and explore optimal hormone replacement therapy for patients with adrenal insufficiency.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Patients with adrenal insufficiency or suspected adrenal insufficiency who are scheduled to be admitted to our department, aged 20 years or older and younger than 80 years, regardless of sex.
Key exclusion criteria - Patients who did not provide informed consent; patients with concomitant conditions that may cause peripheral neuropathy (eg, diabetes mellitus or current or previous treatment with chemotherapy
associated with peripheral neuropathy).
Target Size - 150
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 07 Day
Anticipated trial start date - 2026 Year 08 Month 19 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071585
Disclaimer: Curated by HT Syndication.
